Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjon

Showing results (421-430 of 441) with videos related to

Pageof 45
Sort By:
Nature Neuroscience|August 12, 2020
Author Correction: AHR is a Zika virus host factor and a candidate target for antiviral therapyFederico Giovannoni, Irene Bosch, Carolina Manganeli Polonio, et al.
Lancet (London, England)|November 5, 2013
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trialClemens von Birgelen, Hanim Sen, Ming Kai Lam, et al.
Nature Neuroscience|July 22, 2020
AHR is a Zika virus host factor and a candidate target for antiviral therapyFederico Giovannoni, Irene Bosch, Carolina Manganeli Polonio, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2024
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party studyChristo Tsilifis, Carsten Speckmann, Su Han Lum, et al.
JACC. Cardiovascular Interventions|September 1, 2024
Real-World Implementation of a Genotype-Guided P2Y<sub>12</sub> Inhibitor De-Escalation Strategy in Acute Coronary Syndrome PatientsJaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, et al.
BMC Infectious Diseases|July 3, 2023
Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)Tracy R Richardson, Bronwyn Smith, Stephanus T Malherbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2025
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy StudyJayne S Sutherland, Gian D van der Spuy, Jane A Shaw, et al.
Human Reproduction (Oxford, England)|August 14, 2015
Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?R I Tjon-Kon-Fat, A J Bensdorp, P M M Bossuyt, et al.
International Journal of Cardiology|April 22, 2021
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patientsDaniel M F Claassens, Marieke E Gimbel, Thomas O Bergmeijer, et al.
Pageof 45

Showing results (421-430 of 441) with videos related to

Sort By:
Pageof 45
Nature Neuroscience|August 12, 2020
Author Correction: AHR is a Zika virus host factor and a candidate target for antiviral therapyFederico Giovannoni, Irene Bosch, Carolina Manganeli Polonio, et al.
Lancet (London, England)|November 5, 2013
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trialClemens von Birgelen, Hanim Sen, Ming Kai Lam, et al.
Nature Neuroscience|July 22, 2020
AHR is a Zika virus host factor and a candidate target for antiviral therapyFederico Giovannoni, Irene Bosch, Carolina Manganeli Polonio, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2024
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party studyChristo Tsilifis, Carsten Speckmann, Su Han Lum, et al.
JACC. Cardiovascular Interventions|September 1, 2024
Real-World Implementation of a Genotype-Guided P2Y<sub>12</sub> Inhibitor De-Escalation Strategy in Acute Coronary Syndrome PatientsJaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, et al.
BMC Infectious Diseases|July 3, 2023
Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)Tracy R Richardson, Bronwyn Smith, Stephanus T Malherbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2025
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy StudyJayne S Sutherland, Gian D van der Spuy, Jane A Shaw, et al.
Human Reproduction (Oxford, England)|August 14, 2015
Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?R I Tjon-Kon-Fat, A J Bensdorp, P M M Bossuyt, et al.
International Journal of Cardiology|April 22, 2021
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patientsDaniel M F Claassens, Marieke E Gimbel, Thomas O Bergmeijer, et al.
Pageof 45